Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 2013 , Vol 4, Issue 1
Chemotherapy In Hemodialysis Patients
Metin Sarıkaya1, Mustafa Yıldırım2, Funda Sarı1
1Antalya Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, Antalya, Türkiye
2Antalya Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kliniği, Antalya, Türkiye
Treatment of malignancy in patients with chronic renal failure has been an issue of debate since mid 1970's. Any stage of chronic renal disease is seen in patients with malignancy with a high frequency such as 50-60%. Nowadays, incidence of end-stage renal failure is increasing worldwide and the majority of these patients undergo hemodialysis. Doses of the cytotoxic treatment and application of the drugs with appropriate timing according to the hemodialysis periods is important in these patients because of the side effects and efficacy of the treatment; when there is a coexisting malignancy. In this paper, tolerance and dose arrangement of the chemotheraupetics used in treatment of solid tumors in patient with end stage renal failure who undergo hemodialysis have been reviewed with current litearure. Keywords : hemodialysis, cancer, chemotherapy